David R. Wells, Chief Financial Officer at ENDRA Life Sciences Inc. (NDRA), sold 35,000 shares at $0.90 ($32K) on 2021-01-05, disclosed to the SEC on 2021-01-06.
Scheduled sale ($32k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.90 | 100 | $90 | 0.3% |
| 2 | $0.90 | 34,900 | $31K | 99.7% |
| Total | $0.90 avg | 35,000 | $32K | 100% |
| Filing → |
| SINX | BUY | 2011-01-03 | $1K | — | Filing → |
| SINX | BUY | 2010-12-15 | $1K | — | Filing → |
| SINX | BUY | 2010-12-10 | $1K | — | Filing → |